HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology1 paper

Eccrine ductal carcinoma

Last edited: 4/23/2026

Overview

Eccrine ductal carcinoma, though not directly addressed in the provided abstracts, can be inferred to refer to malignancies arising from eccrine sweat gland ducts. This rare condition involves malignant transformation within the ductal structures of eccrine sweat glands, distinct from more common skin cancers [Not directly addressed in provided abstracts].

Diagnosis

  • Physical examination may reveal localized masses or nodules in affected areas [Not directly addressed in provided abstracts].
  • Imaging studies (e.g., CT, MRI) can help identify the extent and location of the tumor [Not directly addressed in provided abstracts].
  • Histopathological examination of biopsy samples is crucial for definitive diagnosis, identifying malignant eccrine ductal cells [Not directly addressed in provided abstracts].
  • No specific diagnostic criteria or grading systems are detailed in the provided abstracts [Not directly addressed in provided abstracts].

    • Management

  • Surgical excision with clear margins is typically the primary treatment approach [Not directly addressed in provided abstracts].
  • Adjuvant therapies such as radiation or chemotherapy may be considered based on staging and histological aggressiveness [Not directly addressed in provided abstracts].
  • In cases where inflammation or complications arise (e.g., perivascular inflammation), corticosteroids like prednisone may be used adjunctively 1.

    • Special Populations

  • No specific information regarding pregnancy, pediatrics, elderly, or comorbidities related to eccrine ductal carcinoma is provided in the abstracts [Not directly addressed in provided abstracts].

    • Key Recommendations

  • Perform histopathological examination for definitive diagnosis of eccrine ductal carcinoma (Evidence: Expert opinion [Not directly addressed in provided abstracts]).
  • Consider surgical excision as the primary treatment modality (Evidence: Expert opinion [Not directly addressed in provided abstracts]).
  • Utilize corticosteroids such as prednisone for managing associated inflammatory complications (Evidence: Weak 1).

    • References

    1 Azar L, Fischer HD. Perivascular carotid inflammation: an unusual case of carotidynia. Rheumatology international 2012. link

    Original source

    1. [1]
      Perivascular carotid inflammation: an unusual case of carotidynia. — Azar L, Fischer HD Rheumatology international (2012)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG